Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Torrent Pharmaceuticals Revenue

Torrent Pharmaceuticals had revenue of 49.79B INR in the quarter ending September 30, 2026, with 50.79% growth. This brings the company's total for the last twelve months to 174.00B, up 42.06% year-over-year. In the fiscal year ending March 31, 2026, Torrent Pharmaceuticals had annual revenue of 139.80B with 21.39% growth.

• Revenue (ttm): 174.00B
• Revenue Growth: +42.06%
• P/S Ratio: 9.97
• Revenue / Employee: 9.53M
• Employees: 18,258
• Market Cap: 1.74T

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 81.61B 58.4%
• Other Countries 18.45B 13.2%
• United States 13.63B 9.7%
• Brazil 13.62B 9.7%
• Germany 12.49B 8.9%

Fiscal year ended Mar 31, 2026 See the full Torrent Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	139.80B	24.64B	21.39%
Mar 31, 2025	115.16B	7.88B	7.35%
Mar 31, 2024	107.28B	11.08B	11.51%
Mar 31, 2023	96.20B	11.12B	13.07%
Mar 31, 2022	85.08B	5.03B	6.29%

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error